JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB301986

Human EPHX2 knockout K562 cell line

Be the first to review this product! Submit a review

|

(0 Publication)

EPHX2 KO cell line available to order. KO validated. Free of charge wild type control available. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
1 Images
Next Generation Sequencing - Human EPHX2 knockout K562 cell line (AB301986)
  • NGS

Lab

Next Generation Sequencing - Human EPHX2 knockout K562 cell line (AB301986)

79 bp deletion after Asn123 of the WT protein

Key facts

Cell type

K-562

Species or organism

Human

Tissue

Blood

Form

Liquid

form

Disease

Chronic Myelogenous Leukemia

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab301986-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"Human EPHX2 knockout K562 cell line kit component", "number":"AB301986-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab301986-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"Human EPHX2 knockout K562 cell line kit component", "number":"AB301986-CMP01", "productcode":"" }, { "size":"1 x 1000000 Cells/vial", "name":"Human wild-type K562 cell line kit component", "number":"AB301986-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
EPHX2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water for bath approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method. Based on cell count, seed cells in an appropriate cell culture flask at a density of 2x105 cells/mL. Seeding density is given as a guide only and should be scaled to align with individual lab schedules.
4. Incubate the culture at 37°C incubator with 5% CO2. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x105 cells/mL is recommended.
  • Subculture when cells reach 1x106 cells/mL.
Culture medium

IMDM + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

EPHX2 also known as soluble epoxide hydrolase is an enzyme that plays a mechanical role in the metabolism of epoxides to diols. The enzyme has a molecular mass of approximately 62 kDa. Scientists find EPHX2 primarily in the liver but it also expresses in other tissues such as the heart kidney and vasculature. Its diverse expression across different organs suggests its involvement in various physiological functions.
Biological function summary

Soluble epoxide hydrolase regulates the hydrolysis of epoxides which affects signaling molecules involved in inflammation and vascular tone. EPHX2 does not directly form a complex but functions within cellular environments to modulate lipid signaling pathways. Through its enzymatic action it converts epoxyeicosatrienoic acids (EETs) which helps to control vasodilation and anti-inflammatory responses.

Pathways

The enzyme soluble epoxide hydrolase integrates into the arachidonic acid metabolism pathway and the cytochrome P450 signaling pathway. In these pathways it interacts with metabolites like EETs influencing lipid signaling and inflammatory processes. Additionally its activity relates to proteins such as cyclooxygenase and lipoxygenase which participate in lipid mediator biosynthesis.

EPHX2 has links to cardiovascular diseases and chronic inflammation conditions. Altered EPHX2 activity may contribute to dysregulated blood pressure a factor in hypertension. Moreover the enzyme associates with other proteins like angiotensin-converting enzyme (ACE) which also plays a role in cardiovascular homeostasis. This relationship underlines the potential therapeutic importance of targeting EPHX2 in disease management.

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Suspension

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com